Fidasimtamab
Modify Date: 2025-08-27 08:51:03
Fidasimtamab structure
|
Common Name | Fidasimtamab | ||
|---|---|---|---|---|
| CAS Number | 2377419-89-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FidasimtamabFidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity[1]. |
| Name | Fidasimtamab |
|---|
| Description | Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |